INFORME INAHTA - INFORME INAHTA
Publicador de contenidos
Objetivo: Health Technology Wales undertook an evidence review to address the following question: Is transcatheter aortic valve implantation (TAVI) clinically and cost effective for severe symptomatic aortic stenosis in adults who are assessed by a heart team as being operable but at intermediate surgical risk? This review is an adaptation and update of the Scottish Health Technologies Group (SHTG) Evidence note 91: Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis at intermediate surgical risk (SHTG 2019).
Autoría: Health Technology Wales
Año de publicación: 2020